Evaluation of Silibinin Effects on the Viability of HepG2 (Human hepatocellular liver carcinoma) and HUVEC (Human Umbilical Vein Endothelial) Cell Lines

Human hepatocellular carcinoma is one of the most common recurrent malignancies since there is no effective therapy for it. Silibinin, a widely used drug and supplement for various liver disorders, demonstrated anti-cancer effects on human hepatocellular carcinoma, human prostate adenocarcinoma cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Vakili Zahir, Niki, Nakhjavani, Maryam, Hajian, Parastoo, Shirazi, Farshad H, Mirzaei, Hamidreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937096/
https://www.ncbi.nlm.nih.gov/pubmed/29755557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937096/
https://www.ncbi.nlm.nih.gov/pubmed/29755557

Ejemplares similares